Latanoprost
Prostaglandin Analogues
Sold as Catiolanze · LATOP · IYUZEH · XALATAN · XALACOM
- Drug class
- Prostaglandin Analogues
- Availability
- Prescription only
- Routes
- Ophthalmic
- Markets covered
- 4
- Products on record
- 71
- FDA reports (12 mo)
- 2,401
Overview
Latanoprost is an active pharmaceutical ingredient in the Prostaglandin Analogues group (S01EE). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 44 | May 29, 2026 |
| CA Canada | Health Canada | 24 | March 5, 2026 |
| US United States | FDA | 2 | November 29, 2024 |
| EU European Union | EMA | 1 | February 13, 2024 |
GBUnited Kingdom· MHRA
44 products
Uses
Reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension. Reduction of elevated intraocular pressure in paediatric patients with elevated intraocular pressure and paediatric glaucoma.
How to take
CACanada· Health Canada
24 products
Uses
XALATAN (latanoprost) is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. XALATAN may be used for the reduction of intraocular pressure in patients with chronic angle-closure glaucoma who underwent peripheral iridotomy or laser iridoplasty.
3 Pediatrics). 4 Geriatrics Geriatrics: Based on the data submitted and reviewed by Health Canada, there is no overall difference in the safety and efficacy of XALATAN use in the geriatric patient population.
How to take
USUnited States· FDA
2 products
Uses
1 INDICATIONS AND USAGE Latanoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Latanoprost ophthalmic solution is a prostaglandin F 2α analogue indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
(1)
How to take
EUEuropean Union· EMA
1 product
Uses
Catiolanze is indicated for the reduction of elevated intraocular pressure (IOP) in adult patients with open angle glaucoma or ocular hypertension. Catiolanze is indicated for the reduction of elevated IOP in children from 4 years of age and adolescents with elevated IOP and paediatric glaucoma.
How to take
Drug interactions
Known interactions involving Latanoprost. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 293. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL157640200 · revised February 21, 2025
- [2]Health Canada (DPD) · 02231493 · revised March 22, 2025
- [3]FDA DailyMed · 113abcc6-6e5c-4a… · revised November 29, 2024 [PDF]
- [4]European Medicines Agency · EMEA/H/C/005933 · revised February 13, 2024
- [5]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.